Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

211 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Next-generation des-r-carboxy prothrombin for immunohistochemical assessment of vascular invasion by hepatocellular carcinoma.
Yamazaki S, Takayama T, Kurokawa T, Shimamoto N, Mitsuka Y, Yoshida N, Higaki T, Sugitani M. Yamazaki S, et al. Among authors: sugitani m. BMC Surg. 2020 Sep 14;20(1):201. doi: 10.1186/s12893-020-00862-0. BMC Surg. 2020. PMID: 32928172 Free PMC article.
Quantitative Ultrasound Image Analysis Helps in the Differentiation of Hepatocellular Carcinoma (HCC) From Borderline Lesions and Predicting the Histologic Grade of HCC and Microvascular Invasion.
Matsumoto N, Ogawa M, Kaneko M, Kumagawa M, Watanabe Y, Hirayama M, Nakagawara H, Masuzaki R, Kanda T, Moriyama M, Takayama T, Sugitani M. Matsumoto N, et al. Among authors: sugitani m. J Ultrasound Med. 2020 Aug 25. doi: 10.1002/jum.15439. Online ahead of print. J Ultrasound Med. 2020. PMID: 32840896
Involvement of the Interferon Signaling Pathways in Pancreatic Cancer Cells.
Fujisawa M, Kanda T, Shibata T, Sasaki R, Masuzaki R, Matsumoto N, Nirei K, Imazu H, Kuroda K, Sugitani M, Takayama T, Moriyama M. Fujisawa M, et al. Among authors: sugitani m. Anticancer Res. 2020 Aug;40(8):4445-4455. doi: 10.21873/anticanres.14449. Anticancer Res. 2020. PMID: 32727774
Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
Midorikawa Y, Yamamoto S, Tatsuno K, Renard-Guillet C, Tsuji S, Hayashi A, Ueda H, Fukuda S, Fujita T, Katoh H, Ishikawa S, Covington KR, Creighton CJ, Sugitani M, Wheeler DA, Shibata T, Nagae G, Takayama T, Aburatani H. Midorikawa Y, et al. Among authors: sugitani m. Cancer Res. 2020 Sep 15;80(18):3810-3819. doi: 10.1158/0008-5472.CAN-20-0225. Epub 2020 Jul 8. Cancer Res. 2020. PMID: 32641413
Hepatic hemangioma supplied by abnormal portal vein: A case report.
Ogawa M, Matsumoto N, Kaneko M, Kumagawa M, Watanabe Y, Hirayama M, Moriyama M, Higaki T, Takayama T, Sugitani M. Ogawa M, et al. Among authors: sugitani m. J Clin Ultrasound. 2020 May;48(4):231-234. doi: 10.1002/jcu.22790. Epub 2019 Nov 13. J Clin Ultrasound. 2020. PMID: 31721219
Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer's Disease: A 24-Week, Open-Label, Multicenter Study in Japan.
Ueda K, Katayama S, Arai T, Furuta N, Ikebe S, Ishida Y, Kanaya K, Ouma S, Sakurai H, Sugitani M, Takahashi M, Tanaka T, Tsuno N, Wakutani Y, Shekhawat A, Das Gupta A, Kiyose K, Toriyama K, Nakamura Y. Ueda K, et al. Among authors: sugitani m. Dement Geriatr Cogn Dis Extra. 2019 Aug 15;9(2):302-318. doi: 10.1159/000501364. eCollection 2019 May-Aug. Dement Geriatr Cogn Dis Extra. 2019. PMID: 31572426 Free PMC article.
Conversion of human fibroblasts into multipotent cells by cell-penetrating peptides.
Kikuchi J, Hayashi N, Osada N, Sugitani M, Furukawa Y. Kikuchi J, et al. Among authors: sugitani m. Biochem Biophys Res Commun. 2019 Oct 8;518(1):134-140. doi: 10.1016/j.bbrc.2019.08.021. Epub 2019 Aug 10. Biochem Biophys Res Commun. 2019. PMID: 31409482
[A Case of Advanced Gastric Cancer with Bone Marrow Metastasis Treated with Low-Dose Combination Chemotherapy Containing S-1 and Docetaxel].
Watabe M, Kochi M, Nishimaki H, Kano H, Tamegai H, Shimizu H, Matsuno Y, Kawai T, Masuda S, Sugitani M, Fujii M, Takayama T. Watabe M, et al. Among authors: sugitani m. Gan To Kagaku Ryoho. 2019 May;46(5):933-936. Gan To Kagaku Ryoho. 2019. PMID: 31189819 Japanese.
The Influence of Age on the Outcomes of Traumatic Brain Injury: Findings from a Japanese Nationwide Survey (J-ASPECT Study-Traumatic Brain Injury).
Yamagami K, Kurogi R, Kurogi A, Nishimura K, Onozuka D, Ren N, Kada A, Nishimura A, Arimura K, Ido K, Mizoguchi M, Sakamoto T, Kayama T, Suzuki M, Arai H, Hagihara A, Iihara K; J-ASPECT Study Collaborators. Yamagami K, et al. World Neurosurg. 2019 Oct;130:e26-e46. doi: 10.1016/j.wneu.2019.05.140. Epub 2019 May 24. World Neurosurg. 2019. PMID: 31132488
Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study.
Matsumoto Y, Kobayashi T, Shimura Y, Kawata E, Nagoshi H, Ohshiro M, Sugitani M, Shimura K, Iwai T, Fuchida SI, Yoshida M, Kiyota M, Mizutani S, Chinen Y, Takimoto-Shimomura T, Nakao M, Kaneko H, Uchiyama H, Uoshima N, Nishigaki H, Kobayashi Y, Horiike S, Shimazaki C, Taniwaki M, Kuroda J; Kyoto Clinical Hematology Study Group (KOTOSG). Matsumoto Y, et al. Among authors: sugitani m. Int J Hematol. 2019 Jul;110(1):77-85. doi: 10.1007/s12185-019-02650-w. Epub 2019 May 24. Int J Hematol. 2019. PMID: 31127456 Clinical Trial.
211 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback